A clinical study to evaluate the effect of champaka agada and haridra khanda in the treatment of sheetapitta

Efficacy of Champaka Agada and Haridra Khanda in Sheetapitta with special Reference to Urticaria: A Randomized Open-Label Clinical Study - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100152

Enrollment

Registered

2026-01-01

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from Sheetapitta having Age group between-20 years-50 years, irrespective of Gender, Religion, Occupation. Diagnosed cases of Sheetapitta (Urticaria) upto 27 UAS 7 score (mild and moderate cases)

Exclusion criteria

Exclusion criteria: Diagnosed cases of Sheetapitta (Urticaria) above 27 UAS 7 score (Severe cases) Patients currently on treatment with Antihistamines Pregnant or lactating women Known cases of other skin diseases such as Psoriasis, Ezema, Fungal skin infections etc. Patients suffering from uncontrolled Diabetes and Hypertension Patients who are already diagnosed with Renal disease, Liver disease, CAD, IHD

Design outcomes

Primary

Measure	Time frame
Change in UAS7 Score, DLQI, and Subjective parameters from baseline to the 28th dayTimepoint: Change in UAS7 Score, DLQI, and Subjective parameters from baseline to the 28th day	—

Secondary

Measure	Time frame
1 Changes in IgE, ESR, and AEC 2 Safety outcomes Adverse drug reactions Timepoint: follow up 7th day 14th day 21st day 28th day	—

Countries

India

Contacts

Public ContactDr Narayan Gramopadhye

All India Institute of Ayurveda goa

nggramo@gmail.com09423272806

Outcome results